This compound has many therapeutic properties, such as protective effects against the influenza A virus, which induces pneumonia through cytokine modulation and the NF-κB pathway [63], as well as anti-cancer effects via G0/G1 arrest [64], anti-asthmatic effect through mucolysis, downregulation of TNF-α and IL-1β, inactivation of the NF-κB and TLR4 pathways [64,65,66,67], and anti-inflammatory and anti-oxidative effects via inhibition of NF-κB translocation and the JNK pathway (Figure 4) [68]. The gene discussed is NFKB1; the disease is pneumonia.